PT Siloam International Hospitals Tbk, together with its subsidiaries, engages in the provision of healthcare services in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; vaccines; and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID-19 tests; radiation therapy; teleconsultation services; and clinical services in the areas of cardiology, neurosciences, oncology, orthopedics, urology, as well as emergency medical care. In addition, the company operates an oncology center for the treatment of lung, breast, hematologic, gastrointestinal, gynecology, and prostate cancers. Further, it engages in trading, development, mining, agriculture, service, land transportation, industry, printing, plantation, forestry, electrical, mechanical, engineering, construction, and real estate businesses; computer programming activities; provision of management consulting, trust, financing, financial entities, retail, professional, and scientific and technical activities; and web portal and/or digital platform business. The company was formerly known as PT Sentralindo Wirasta. PT Siloam International Hospitals Tbk was founded in 1996 and is headquartered in Tangerang, Indonesia. PT Siloam International Hospitals Tbk operates as a subsidiary of Sight Investment Company Pte. Limited.